收藏切换
Clinical research progress on therapeutic drugs for homozygous familial hypercholesterolemia
收藏切换
Yan REN1, 2, Lu WANG2, Ziwen DING2, Yan ZHENG3, Na NI2, 3, Yunliang QIU4, *, Junlong WANG3, *
World Clinical Drug | 2022, 43(6) : 782 - 786
Less
收藏切换
World Clinical Drug | 2022, 43(6): 782-786
• Review •
Clinical research progress on therapeutic drugs for homozygous familial hypercholesterolemia
Full
Yan REN1, 2, Lu WANG2, Ziwen DING2, Yan ZHENG3, Na NI2, 3, Yunliang QIU4, *, Junlong WANG3, *
Affiliations
  • 1.School of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai 201620, China
  • 2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China
  • 4.National Shanghai Center for New Drug Safety Evaluation and Research, China State Institute of Pharmaceutical Industry, Shanghai 201203, China
Published: 2022-06-10 doi: 10.13683/j.wph.2022.06.023
Outline
收藏切换

Homozygous familial hypercholesterolaemia (HoFH) is a severe and rare hypercholesterolemia, which is characterized by a significant increase in low density lipoprotein-cholesterol (LDL-C) and premature atherosclerotic cardiovascular disease. At present, evinacumab, mipomersen, lomitapid and proprotein convertase subtilisin/kexin type 9 inhibitors have been approved for the treatment of HoFH, which effectively solves the problem of the lack of drugs for rare diseases. The article briefly reviewed the clinical research progress on drugs for the treatment of HoFH.

homozygous familial hypercholesterolemia  /  rare disease  /  orphan drug
任燕, 汪璐, 丁子文, 郑岩, 倪娜, 邱云良, 王俊龙. 纯合子家族性高胆固醇血症治疗药物的临床研究进展. 世界临床药物, 2022 , 43 (6) : 782 -786 . DOI: 10.13683/j.wph.2022.06.023
Yan REN, Lu WANG, Ziwen DING, Yan ZHENG, Na NI, Yunliang QIU, Junlong WANG. Clinical research progress on therapeutic drugs for homozygous familial hypercholesterolemia[J]. World Clinical Drug, 2022 , 43 (6) : 782 -786 . DOI: 10.13683/j.wph.2022.06.023
Year 2022 volume 43 Issue 6
9
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.06.023
  • Receive Date:2021-09-23
  • Online Date:2026-11-19
  • Published:2022-06-10
Article Data
Affiliations
History
  • Received:2021-09-23
Affiliations
    1.School of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai 201620, China
    2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
    3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China
    4.National Shanghai Center for New Drug Safety Evaluation and Research, China State Institute of Pharmaceutical Industry, Shanghai 201203, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.06.023
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT